selected publications
-
Availability of Suitable Domestic Cord Blood Grafts for Adult Allograft Recipients With Hematologic Malignancies.
Transplantation and cellular therapy.
2025
Academic Article
GET IT
Times cited: 2 -
US Geriatric Assessment Practices for Older Adults Undergoing Hematopoietic Cell Transplantation or Chimeric Antigen Receptor T Cell Therapy: An American Society for Transplantation and Cellular Therapy Physician Survey from the Aging Special Interest Group and Committee on Practice Guidelines.
Transplantation and cellular therapy.
2025
Information Resource
GET IT
Times cited: 2 -
Precision medicine results from equitable representation.
Bone marrow transplantation.
2024
Academic Article
GET IT
Times cited: 2 -
Safety and Toxicity Profiles of CAR T Cell Therapy in Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis.
Clinical lymphoma, myeloma & leukemia.
2024
Information Resource
GET IT
Times cited: 15 -
Deposition of complement components C5b-9 and MASP2 in tissues is not a feature of GVHD and may assist in discriminating GVHD from thrombotic microangiopathy following allogenic transplantation.
Bone marrow transplantation.
2023
Article
GET IT
Times cited: 3 -
Measurable residual disease after CAR T-cell therapy.
Seminars in hematology.
2023
Information Resource
GET IT
Times cited: 2 -
Screening Chest CT Prior to Allogenic Hematopoietic Stem Cell Transplantation.
Transplantation and cellular therapy.
2023
Academic Article
GET IT
Times cited: 8 -
Wide variation in use and interpretation of gene mutation profiling panels among health care providers of patients with myelodysplastic syndromes: results of a large web-based survey.
Leukemia & lymphoma.
2020
Academic Article
GET IT
Times cited: 6 -
Getting personal with myelodysplastic syndromes: is now the right time?.
Expert review of hematology.
2019
Information Resource
GET IT
Times cited: 9 -
The Rising Era of Immune Checkpoint Inhibitors in Myelodysplastic Syndromes.
Advances in hematology.
2018
Information Resource
GET IT
Times cited: 16 -
Immunosuppressive therapy in myelodysplastic syndromes: a borrowed therapy in search of the right place.
Expert review of hematology.
2018
Information Resource
GET IT
Times cited: 13 -
Fulminant Diabetes in a Patient with Advanced Melanoma on Nivolumab.
Case reports in oncological medicine.
2018
Article
GET IT
Times cited: 78